Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Receivables: 2016-2024

Historic Change in Receivables for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $4.4 million.

  • Collegium Pharmaceutical's Change in Receivables rose 10913.68% to $20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 142.07%. This contributed to the annual value of $4.4 million for FY2024, which is 222.82% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Change in Receivables stood at $4.4 million for FY2024, which was up 222.82% from -$3.6 million recorded in FY2023.
  • Collegium Pharmaceutical's 5-year Change in Receivables high stood at $22.5 million for FY2021, and its period low was -$3.6 million during FY2023.
  • Over the past 3 years, Collegium Pharmaceutical's median Change in Receivables value was $4.4 million (recorded in 2024), while the average stood at $7.5 million.
  • In the last 5 years, Collegium Pharmaceutical's Change in Receivables spiked by 307.63% in 2020 and then slumped by 116.50% in 2023.
  • Collegium Pharmaceutical's Change in Receivables (Yearly) stood at $10.4 million in 2020, then skyrocketed by 117.27% to $22.5 million in 2021, then dropped by 3.30% to $21.8 million in 2022, then slumped by 116.50% to -$3.6 million in 2023, then soared by 222.82% to $4.4 million in 2024.